Suppr超能文献

重组人 MG53 蛋白可预防碱性诱导的小鼠角膜损伤。

Recombinant Human MG53 Protein Protects Against Alkaline-Induced Corneal Injuries in Mice.

机构信息

Dublin Jerome High School, Dublin, OH 43016, USA.

Department of Surgery, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA.

出版信息

Mil Med. 2021 Jan 25;186(Suppl 1):486-490. doi: 10.1093/milmed/usaa357.

Abstract

INTRODUCTION

The current study was designed to test the potential role of recombinant human MG53 (rhMG53) protein on protecting against alkaline-induced corneal injury in mice.

MATERIALS AND METHODS

A round filter paper with 2-mm diameter was soaked in 1 mol/L of NaOH solution. The mouse alkaline injury was generated by placing the filter paper directly on the cornea for 30 seconds and washed with 30-mL saline; 10 µL of rhMG53 solution (20 µg/mL) or saline control was topically administrated on the mouse corneas (twice per day for 10 days). Re-epithelialization was measured by fluorescein staining and imaged by a slit lamp equipped with a digital camera. Clinical neovascularization and opacity scores were measured every day after injury. Ten days after injury, mice were sacrificed and corneas were dissected out for flat mount staining of CD31 for neovascularization.

RESULTS

MG53 was present in both dog aqueous humor and human tears. mg53-/- corneas were more susceptible to alkaline-induced corneal injury. Topical treatment of rhMG53 improved re-epithelialization, suppressed neovascularization, and fibrosis induced by alkaline injury.

CONCLUSIONS

rhMG53 may be an effective means to treat corneal wounding.

摘要

简介

本研究旨在测试重组人 MG53(rhMG53)蛋白在保护小鼠碱性诱导性角膜损伤中的潜在作用。

材料和方法

用 2 毫米直径的圆形滤纸浸泡在 1 摩尔/升的 NaOH 溶液中。通过将滤纸直接放在角膜上 30 秒并用 30 毫升生理盐水冲洗来产生小鼠碱性损伤;将 rhMG53 溶液(20 µg/mL)或生理盐水对照物 10 µL 局部施用于小鼠角膜(每天两次,共 10 天)。通过荧光素染色测量再上皮化,并通过配备数码相机的裂隙灯成像。损伤后每天测量临床新生血管形成和混浊评分。损伤后 10 天,处死小鼠并取出角膜进行 CD31 平置染色以检测新生血管形成。

结果

MG53 存在于犬房水中和人泪液中。mg53-/-角膜对碱性诱导的角膜损伤更敏感。rhMG53 的局部治疗可改善碱性损伤引起的再上皮化、抑制新生血管形成和纤维化。

结论

rhMG53 可能是治疗角膜创伤的有效手段。

相似文献

1
Recombinant Human MG53 Protein Protects Against Alkaline-Induced Corneal Injuries in Mice.
Mil Med. 2021 Jan 25;186(Suppl 1):486-490. doi: 10.1093/milmed/usaa357.
2
MG53 promotes corneal wound healing and mitigates fibrotic remodeling in rodents.
Commun Biol. 2019 Feb 20;2:71. doi: 10.1038/s42003-019-0316-7. eCollection 2019.
4
MG53 Does Not Manifest the Development of Diabetes in Mice.
Diabetes. 2020 May;69(5):1052-1064. doi: 10.2337/db19-0807. Epub 2020 Mar 5.
6
7
Treatment of alkali-injured cornea by cyclosporine A-loaded electrospun nanofibers - An alternative mode of therapy.
Exp Eye Res. 2016 Jun;147:128-137. doi: 10.1016/j.exer.2016.04.016. Epub 2016 May 13.
8
Membrane-delimited signaling and cytosolic action of MG53 preserve hepatocyte integrity during drug-induced liver injury.
J Hepatol. 2022 Mar;76(3):558-567. doi: 10.1016/j.jhep.2021.10.017. Epub 2021 Nov 1.
9
Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring.
Invest Ophthalmol Vis Sci. 2013 Mar 1;54(3):1680-8. doi: 10.1167/iovs.12-10782.
10
The neuroregenerative effects of topical decorin on the injured mouse cornea.
J Neuroinflammation. 2020 May 4;17(1):142. doi: 10.1186/s12974-020-01812-6.

引用本文的文献

1
Development of an Ophthalmic Hydrogel to Deliver MG53 and Promote Corneal Wound Healing.
Pharmaceutics. 2025 Apr 16;17(4):526. doi: 10.3390/pharmaceutics17040526.

本文引用的文献

1
MG53 promotes corneal wound healing and mitigates fibrotic remodeling in rodents.
Commun Biol. 2019 Feb 20;2:71. doi: 10.1038/s42003-019-0316-7. eCollection 2019.
2
Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.
Mol Ther. 2017 Oct 4;25(10):2360-2371. doi: 10.1016/j.ymthe.2017.06.025. Epub 2017 Jul 3.
3
MG53 permeates through blood-brain barrier to protect ischemic brain injury.
Oncotarget. 2016 Apr 19;7(16):22474-85. doi: 10.18632/oncotarget.7965.
4
Modulation of wound healing and scar formation by MG53 protein-mediated cell membrane repair.
J Biol Chem. 2015 Oct 2;290(40):24592-603. doi: 10.1074/jbc.M115.680074. Epub 2015 Aug 25.
5
MG53-mediated cell membrane repair protects against acute kidney injury.
Sci Transl Med. 2015 Mar 18;7(279):279ra36. doi: 10.1126/scitranslmed.3010755.
6
Amelioration of ischemia-reperfusion-induced muscle injury by the recombinant human MG53 protein.
Muscle Nerve. 2015 Nov;52(5):852-8. doi: 10.1002/mus.24619. Epub 2015 Jun 3.
7
Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury.
J Mol Cell Cardiol. 2015 Mar;80:10-19. doi: 10.1016/j.yjmcc.2014.12.010. Epub 2014 Dec 20.
8
Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.
Nat Commun. 2014 Jul 18;5:4387. doi: 10.1038/ncomms5387.
9
An alkali-burn injury model of corneal neovascularization in the mouse.
J Vis Exp. 2014 Apr 7(86):51159. doi: 10.3791/51159.
10
Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy.
Sci Transl Med. 2012 Jun 20;4(139):139ra85. doi: 10.1126/scitranslmed.3003921.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验